Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 07/20/11 → 06/6/15 |
Funding
- Celgene Corporation: $65,097.75
A Phase 1B, Randomized, Placebo Controlled, Multiple Dose Study to Evaluate the Safety of Intravenous Infusion of Human Placenta-Derived Cells (PDA001) for the Treatmen tof Adults with Multiple Sclerosis
- Coyle, Patricia (CoPI)
- Krupp, Lauren (PI)
- Gerber, Oded (CoPI)
Project: Research